Methods of treating immune and inflammatory response with IL-17

Details Methods of treating immune and inflammatory response with IL-17 Methods of treating immune and inflammatory response with IL-17

1998-02-11

2000-08-08

Draper, Garnette D.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 8, 514 12, 514885, 514886, A61K 3800

Patent

active

061002356

ABSTRACT:
Isolated receptors for IL-17, DNA's encoding such receptors, and pharmaceutical compositions made therefrom, and methods of treatment using the IL-17 receptors are disclosed. The isolated receptors can be used to regulate an immune response.

REFERENCES:
Nicholas et al., Virol. 179:1 89; 1990.
Rouvier et al., J. Immunol. 150:5445; 1993.
Albrecht et al., J. Virol. 66:5047; 1992.
Yao, et al., Immunity 3:811; 1995.
GenBank Accession No. H55639.
GenBank Accession No. U31993.
Trofatter et al., Genome Res. 5:214; 1995.
Frommel and Holzhutter, J. Mol. Evol. 21:233; 1985.
Bowie et al., Science 247:1306; 1990.
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, Mertz and LeGrand, eds. 1994; pp 491-495.
Fanslow et al., J. Immunol. 147:535; 1991.
Fanslow et al., Science 248:739; 1990.
Torrance et al., poster presentation, Mar. 7, 1997.

Affiliated with

Also associated with

Rating

Methods of treating immune and inflammatory response with IL-17 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating immune and inflammatory response with IL-17 , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating immune and inflammatory response with IL-17 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1150216